CNNM3

CNNM3 is a membrane-associated magnesium transporter/regulator that mediates Mg²⁺ efflux and modulates divalent cation homeostasis through multiple regulatory interactions. Its CBS-pair domain forms a heterodimeric complex with PRL-2 phosphatase—structurally resolved and regulated by phosphocysteine at the PRL catalytic site—that is required for Mg²⁺ efflux activity and oncogenic transformation (PMID:24632616, PMID:27856537, PMID:26969161). The C-terminal CNBH domain mediates obligate dimerization essential for Mg²⁺ efflux, while CNNM3 additionally binds and stimulates the TRPM7 channel to promote divalent cation influx, a function modulated by ARL15-dependent N-glycosylation and antagonized by PRL-2 (PMID:30341174, PMID:34928937, PMID:36972446). In C. elegans, loss of CNNM orthologs causes Mg²⁺ accumulation and defective gonadogenesis through AMPK-TORC1 signaling, linking CNNM-dependent Mg²⁺ homeostasis to growth control (PMID:27564576).

1. 2004 Low

   Sequence homology to the bacterial CorC Mg²⁺/Co²⁺ efflux system first suggested that CNNM3 functions in divalent cation transport, framing the central hypothesis for all subsequent work.

   Evidence Bioinformatic comparison of mouse Acdp3 to bacterial CorC (35% identity, 55% homology)

   PMID:14723793

   Open questions at the time

   • Purely computational inference with no functional data for CNNM3 itself
   • No direct transport assay performed
   • Immunostaining data shown only for Acdp1, not Acdp3
2. 2014 High

   Functional studies established that CNNM3 mediates Mg²⁺ efflux and that this activity is co-opted by PRL-2 for oncogenic signaling: PRL-2 binds CNNM3's CBS-pair domain to regulate intracellular Mg²⁺ and promote tumor growth.

   Evidence Xenopus oocyte Mg²⁺ efflux assay (pufferfish ortholog); Co-IP, PRL-2 KO mice, xenograft tumor models, Mg²⁺ influx measurements (human)

   PMID:24632616 PMID:24965791

   Open questions at the time

   • Structural basis of PRL-2–CNNM3 interaction not yet resolved
   • Oocyte efflux data from fish ortholog, not human CNNM3
   • Whether CNNM3 is itself the transporter or a regulator of a separate transporter was unresolved
3. 2016 High

   Crystal structure of the PRL-2–CNNM3 CBS-pair complex revealed the molecular interface and demonstrated that phosphocysteine at the PRL active site acts as a Mg²⁺-sensitive switch controlling complex formation and Mg²⁺ efflux, while a single D426A mutation in the CBS loop completely abrogated binding and function.

   Evidence X-ray crystallography, active-site mutagenesis, phosphocysteine detection, whole-cell voltage clamping, Mg²⁺ efflux assays, orthotopic xenograft models

   PMID:26969161 PMID:27856537

   Open questions at the time

   • Whether phosphocysteine regulation is the sole mechanism controlling PRL-CNNM dynamics in vivo
   • Electrophysiological identity of the CNNM3-associated current was undefined
4. 2016 Medium

   Genetic epistasis in C. elegans placed CNNM-mediated Mg²⁺ homeostasis upstream of AMPK-TORC1 signaling in germ cell proliferation, establishing a conserved physiological role beyond cancer.

   Evidence C. elegans cnnm-1;cnnm-3 double mutants, genome-wide RNAi, aak-2 epistasis

   PMID:27564576

   Open questions at the time

   • Genetic analysis used double mutants, so individual contribution of cnnm-3 is unclear
   • Whether AMPK-TORC1 link is conserved in mammals was not tested
5. 2018 High

   Structural determination of the CNBH domain at 1.9 Å resolution showed it forms an obligate dimer (rather than binding cyclic nucleotides), and mutagenesis demonstrated this dimerization is required for Mg²⁺ efflux, defining the domain architecture essential for CNNM3 function.

   Evidence X-ray crystallography, analytical ultracentrifugation, mutagenesis, Mg²⁺ efflux assays

   PMID:30341174

   Open questions at the time

   • Full-length CNNM3 structure not determined
   • How CNBH dimerization communicates with the transmembrane domain is unknown
6. 2021 High

   Beyond Mg²⁺ efflux, CNNM3 was shown to selectively bind and stimulate TRPM7 channel activity to promote divalent cation influx, while ARL15 was identified as a GTPase that promotes CNNM3 N-glycosylation and negatively regulates Mg²⁺ transport.

   Evidence CNNM3/4 KO HEK-293 cells, whole-cell electrophysiology, divalent cation uptake, Co-IP, stable isotope ²⁵Mg²⁺ uptake, ARL15 knockdown

   PMID:34089346 PMID:34928937

   Open questions at the time

   • Whether CNNM3 alone (without CNNM4) is sufficient for TRPM7 stimulation was not resolved
   • Structural basis of CNNM3–TRPM7 interaction is unknown
   • Whether ARL15-mediated glycosylation affects TRPM7 stimulation specifically was not tested
7. 2023 Medium

   An integrated regulatory model emerged: ARL15 promotes CNNM3–TRPM7 complex formation to restrain TRPM7 activity, while PRL-2 displaces ARL15 from CNNM3 to enhance TRPM7 function, with low intracellular Mg²⁺ reducing CNNM3–TRPM7 interaction in a PRL-dependent manner.

   Evidence Genetically encoded Mg²⁺ reporter, Co-IP, overexpression/knockdown, mitochondrial function assays

   PMID:36972446

   Open questions at the time

   • Competitive binding model inferred from overexpression; endogenous stoichiometry not established
   • Mitochondrial effects are correlative and downstream mechanism is unclear
   • In vivo validation of the ARL15–PRL-2 competition on CNNM3 is lacking

• Key open questions include: the full-length structure of CNNM3; whether CNNM3 itself conducts Mg²⁺ or acts as a regulatory subunit for another transporter; the structural basis of the CNNM3–TRPM7 interaction; and whether the PRL-2/ARL15 regulatory axis operates in specific tissues in vivo.
• No full-length CNNM3 structure or cryo-EM model
• Pore-forming versus regulatory identity of CNNM3 unresolved
• Tissue-specific in vivo functions in mammalian models not established